Mubadala Investment Company | Mubadala

01localizedlp-francehero

France Investment
Program

35+

Investments

EUR 3.6 bn

Investment program

Mubadala has been particularly active in France since 2014, expanding its field of intervention significantly over time.

The France Investment Program team benefits from a robust track record, proprietary in-market relationships and a deep understanding of local market dynamics.

Portfolio Highlights

01_inovie-image

Founded in 2010, Inovie has become the leading independent medical diagnostic provider in France and a key player across Southern and Central France specifically.

02_omnipac

Omni-Pac Group is a pan-European designer and producer of moulded fibre packaging products addressing 4 end-markets: egg packaging, fresh food packaging, medical and tailor-made solutions.

03_owkin

Owkin is a French-American start-up leveraging AI to fight against cancer and other medical conditions.

07_sgd_pharma

SGD Pharma is a leading global manufacturer of glass packaging for the pharmaceutical industry.

08_matera

Founded in 2017, Matera disrupts the traditional residential building management industry.

Our Investment Approach

Integrated investment platform bringing together 3 verticals:

no-image-revised

Direct investments in the French mid-market buyout space. Fund investments also considered opportunistically

no-image-revised

Technology and Innovation

Both direct and fund investments in the French venture capital and growth space

no-image-revised

€1bn commitment to Lac 1, a listed equities fund managed by Bpifrance

Our People

andres-rodenas-new

Andres Rodenas de la Vega

Executive Director

marwa-updated

Marwa Abdulrahman

Director

antoine_0

Antoine Bettant

Principal

nasser-bounjou-(1)

Nasser Bounjou

Senior Associate

2-elliott-min

Elliott de Selding

Associate

img_0507_932x1300

Alreem Al-Ali

Analyst

human